Author details

Full Name

Min Jin Ha

Affiliation

ORCID

Career Start Year

2011

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36865225	Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple Myeloma.	bioRxiv	2023
37280434	Author Correction: 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib.	Commun Biol	2023
36648331	A unified mediation analysis framework for integrative cancer proteogenomics with clinical outcomes.		2023
37119866	Association between changes in having of cancer patients in the family and depression: A longitudinal panel study.		2023
35075200	Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations.	Sci Rep	2022
35906256	CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenografts.	Sci Rep	2022
35498876	Sample Selection Bias in Evaluation of Prediction Performance of Causal Models.	Statistical Analysis and Data Mining	2022
35349735	Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes.	Hepatology	2022
35210547	TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model.	Communications Biology	2022
35133007	Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting: A large institutional study.	Int J Cancer	2022
31436549	Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer.	Ann Surg	2021
34239216	Bayesian Structure Learning in Multi-layered Genomic Networks.	Journal of the American Statistical Association	2021
33990543	LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers.	Oncogenesis	2021
33916118	Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or <i>BRCA1</i> Alteration.	Cancers (Basel)	2021
34526717	Structure-based classification predicts drug response in EGFR-mutant NSCLC.	Nature	2021
30596892	Estimation of high-dimensional directed acyclic graphs with surrogate intervention.	Biostatistics	2020
32374631	Personalized Network Modeling of the Pan-Cancer Patient and Cell Line Interactome.	JCO Clin Cancer Inform	2020
31797633	Network-Based Matching of Patients and Targeted Therapies for Precision Oncology.	Pac Symp Biocomput	2020
32253074	Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes.	Eur J Surg Oncol	2020
33371887	Compositional zero-inflated network estimation for microbiome data.	BMC Bioinformatics	2020
32903557	Intravenous Immunoglobulin G Suppresses Heat Shock Protein (HSP)-70 Expression and Enhances the Activity of HSP90 and Proteasome Inhibitors.	Front Immunol	2020
33415011	KRT-232 and navitoclax enhance trametinib's anti-Cancer activity in non-small cell lung cancer patient-derived xenografts with KRAS mutations.	Am J Cancer Res	2020
30867218	Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer.	Clin Cancer Res	2019
31842363	Semen Cuscutae Administration Improves Hepatic Lipid Metabolism and Adiposity in High Fat Diet-Induced Obese Mice.	Nutrients	2019
30051914	Bayesian inference of hub nodes across multiple networks.	Biometrics	2019
31186248	An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses.	Cancer Immunol Res	2019
31178611	Bayesian Hierarchical Varying-sparsity Regression Models with Application to Cancer Proteogenomics.	J Am Stat Assoc	2019
29194470	iDINGO-integrative differential network analysis in genomics with Shiny application.		2018
30297783	Personalized Integrated Network Modeling of the Cancer Proteome Atlas.	Sci Rep	2018
27881578	Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer.	Clin Cancer Res	2017
27342398	Idelalisib Impacts Cell Growth through Inhibiting Translation-Regulatory Mechanisms in Mantle Cell Lymphoma.	Clinical Cancer Research	2017
26406114	PenPC: A two-step approach to estimate the skeletons of high-dimensional directed acyclic graphs.	Biometrics	2016
27349182	Beneficial effects of voglibose administration on body weight and lipid metabolism via gastrointestinal bile acid modification.	Endocrine Journal	2016
26148744	DINGO: differential network analysis in genomics.		2015
25861215	Prognostic gene signature identification using causal structure learning: applications in kidney cancer.	Cancer Informatics	2015
24845967	Partial correlation matrix estimation using ridge penalty followed by thresholding and re-estimation.	Biometrics	2014
24728292	Heritability and genomics of gene expression in peripheral blood.	Nat Genet	2014
20952501	In vitro screening for population variability in chemical toxicity.	Toxicological Sciences	2011